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ABSTRACT
Brain tumors (BTs) are a common pediatric malignancy. Improved
treatment has resulted in higher survival rates. There is, however,
increasing concern about adverse effects of the disease and its treat-
ment, including effects on social competence (i.e. effective social func-
tioning in everyday life). The aim of this study is to examine multiple
levels of social competence (i.e. social skills and social adjustment) in
newly diagnosed pediatric BT patients. Thirty newly diagnosed BT
patients aged 5–12 years were assessed shortly after diagnosis with a
neuropsychological test battery focusing on social competence,
including tests for IQ, social skills (i.e. social-affective and executive
functioning) and social adjustment (rated by parents and teachers).
Their performance was compared to 95 healthy controls who com-
pleted the same assessment. Patients and healthy controls were
largely comparable with regard to demographic and environmental
factors and did not differ on measures of IQ, social skills and social
adjustment. Furthermore, age was found to have a positive significant
effect on social skills independent of group. Shortly after diagnosis,
pediatric BT patients did not perform different from healthy controls
on IQ and measures of social skills and social adjustment. This is
an encouraging finding. However, because of potentially neurotoxic
adjuvant therapy and the ongoing development of social skills,
longitudinal follow-up studies are needed to investigate long-term
outcome regarding social competence in BT survivors.
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Introduction
With the increased survival of pediatric brain tumor (BT) patients, there is a growing
attention for the late effects of the disease and its treatment. Studies in pediatric BT sur-
vivors show impairment in social competence (i.e. effective social functioning in every-
day life) which puts patients at risk of developing psychological problems. Social
competence is an important predictor of quality of life and also of (later) academic,
vocational and romantic functioning. Currently, it is unclear how, when and at which
level(s) of social competence these deficits arise in BT survivors.
The current study is the first to investigate multiple levels of social competence (i.e.
social skills and social adjustment) in newly diagnosed BT patients prospectively.
Patients between the ages of five to twelve were assessed with tests for intelligence,
social-affective and executive functions (i.e. social skills) and social adjustment and
compared to healthy controls. No differences were found between BT patients and
healthy controls regarding social skills and social adjustment. Age had a significant posi-
tive effect on social skills which supports the ongoing development of social competence
throughout childhood.
It is comforting and of clinical and scientific relevance for pediatric BT patients, their
family and clinicians to know that social competence, despite its complexity, appears
not to be significantly affected in the early stage of the disease. However, adjuvant treat-
ment, particularly cranial radiation therapy, may contribute to later poor social skills
and adjustment. Furthermore, brain damage related to the tumor and/or surgery may
only result in obvious deficits many years later. A follow-up study of these patients has,
therefore, been planned in order to study social competence in brain tumor survivors
several years after diagnosis.
Introduction
Brain tumors (BTs) are the second most common pediatric malignancy, accounting
for approximately 20–25% of pediatric cancers. Average long-term (i.e. 5 year) survival
is around 60%.1 Medical treatment includes surgery, cranial or craniospinal radiation
(CRT) and/or chemotherapy.2,3 With improved survival, increasing concern has
emerged about adverse late effects of the disease and its treatment. Deleterious
late effects include neurological, endocrine and (neuro)psychological impairment with sub-
sequent negative effects on school career, employment and quality of life.3 Furthermore,
psychosocial functioning and in particular social competence (i.e. effective social functioning
in everyday life) appears to be affected in BT survivors and can increase the risk of
developing psychological problems.4 Currently, it is unclear how, when and at which
level(s) of social competence these deficits arise in pediatric BT patients.
Social competence is defined as a multi-level construct consisting of three interrelated
factors (Figure 1).5 The first factor, social skills, refers to the child’s cognitive functions
that are relevant for competent social functioning: social-affective and executive func-
tions. Social skills influence the efficiency of the child’s social interaction or performance
(factor 2) in daily life (e.g. being prosocial, aggressive, withdrawn). The extent to which
the child’s performance is developmentally appropriate (perceived by self and others)
constitutes social adjustment (factor 3). Schulte and Barrera concluded in their review
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that BT survivors experience persisting social adjustment problems.4 Deficits in social-
affective functions (i.e. the ability to understand and interact with other people) and
executive functions (i.e. cognitive functions needed for efficient and goal-directed
behavior) have also been shown in BT patients after treatment.6–12 The few pretreat-
ment studies on social adjustment or (parent rated) executive functioning reported
group scores within the normal range.13–15 So far, none of the studies examined social-
affective and executive functioning (using neuropsychological tests) as well as social
adjustment in newly diagnosed BT patients before the start of adjuvant therapy. Social-
affective and executive functions are subserved by a complex network of brain
structures including (pre)frontal and temporal areas, the anterior cingulate cortex, the
amygdala, anterior insula and the cerebellum.6,16–18 This network, which is still develop-
ing throughout childhood and adolescence, may be affected by brain damage caused by
the BT itself, surgical procedures and/or CRT. This makes age an essential variable in
determining social consequences of brain damage.19 So far, the factor consistently found
to be negatively related to development of social skills and social adjustment in pediatric
BT patients is time since diagnosis.4,9 Other possible risk factors include a history of
CRT and a younger age at diagnosis.7,9,20 Furthermore, factors like premorbid function-
ing, intellectual ability, social context and family situation (e.g. socio-economic status
(SES), number of parents in the home) as well as the psychological impact of having a
serious (chronic) illness are also of importance.5,20–23
The aim of the current study is to examine multiple levels of social competence (i.e.
social skills and social adjustment) in newly diagnosed pediatric BT patients compared
to healthy controls.
Materials and methods
Participants
BT patients were recruited between 2011 and 2014 through four hospitals in the
Netherlands and Belgium: University Medical Center Groningen (UMCG), Radboud
University Medical Center Nijmegen, VU University Medical Center Amsterdam and
University Hospitals Leuven (UZL). Patients, parents and teachers were asked for partici-
pation when the child was newly diagnosed, aged between 5 and 12 with a stable medical
condition (e.g. no poor prognosis and with a life expectancy of >1 year). Exclusion crite-
ria were autistic spectrum disorder (ASD), history of brain disease or neurological
Figure 1. Simplified model of social competence. An adapted version of Yeates’ integrative, heuristic
model of social competence in children with brain disorders.5
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condition that affected normal development, IQ below 70 or severe sensory handicaps
and/or behavioral problems hampering reliable neuropsychological assessment.
In total, 35 patients were included and assessed. Five children were excluded after
assessment because of genetic disorders (n¼ 2), ASD (n¼ 1), abnormal development
due to prematurity (n¼ 1) or assessment after receiving CRT (n¼ 1). Consequently, 30
patients were included (50% girls) for further analysis. All children underwent neuro-
surgical intervention (i.e. resection or biopsy). Fifteen children were assessed before
brain surgery, 14 children were assessed after surgery but before receiving adjuvant
therapy. In one case, only questionnaires were administered. In case of hydrocephalus
and/or heightened intracranial pressure, assessments were scheduled after drain place-
ment or third ventriculostomy (n¼ 5). All children had Dutch as a first language. Mean
age at diagnosis was 8 years and 4months and mean age at assessment was 8 years and
5months. On average, patients that were seen before surgery were 11months older at
time of assessment than patients assessed after surgery.
During the same period, healthy Dutch and Flemish children were randomly selected
per class from four primary schools. Flemish children were also recruited through per-
sonal contacts of the researchers. To create a control group with an equal representation
of different age groups and an average IQ within 1 SD of the population mean, a pre-
selection of children was made based on age and school performance (i.e. focusing on the
lower scoring half of the class) at two additional Dutch primary schools. After the pre-
selection, a random selection was made. Inclusion and exclusion criteria for healthy con-
trols were similar to those of patients. In total, 108 children were included and assessed.
Four children were removed from the sample after assessment due to IQ below 70 (n¼ 1),
rheumatoid arthritis (n¼ 1) or ASD (n¼ 2). Another nine children were randomly
removed because one of their siblings also participated in this study. The final sample con-
sisted of 95 children (55% girls) with a mean age at assessment of 8 years and 9months.
This study was approved by the UMCG Medical Ethical Committee and the UZL
Ethical Board. All parents, teachers and children aged 12 years and older gave their
informed consent before study inclusion.
Measures
Social-affective functions
The Facial Affect Recognition (FAR) subtest of the NEPSY-II-NL was administered in
all children to assess the ability to discriminate between facial expressions. The NEPSY-
II-NL Theory of Mind (ToM) subtest was used in all children to examine the ability to
understand beliefs, intentions, deception, emotion, imagination and pretending (i.e.
basic ToM). The reliability of both subtests is adequate. The validity of these subtests
seems acceptable, however this judgement is based on a minimal amount of information
presented in the manual.24 In children aged 8 years and over, complex ToM was
assessed with a Dutch translation of a short form of the Strange Stories Test (SST).25,26
Because the SST is an experimental test, no research on reliability and validity has been
conducted. However, the SST is sensitive to mentalizing deficits in children with high
functioning ASD and shows a moderate intercorrelation with classic false belief tasks.25
The total correct scores for all tests were used for analysis.
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Executive functioning
The Digit Span Backward subtest of the Wechsler Intelligence Scales for Children
(WISC-III-NL) or the Numbers Backward subtest from the Children’s Memory Scale
was administered from 6 years onward to assess working memory (WM). Reliability of
both subtests is acceptable.27,28 The Trail Making Test (TMT) intermediate form was
administered from 8 years onward and the time needed to complete part B was used as
a measure of cognitive flexibility.29 Reliability of part B seems acceptable, the test is sen-
sitive to brain damage in children and associated with vocational outcome in adulthood
after childhood traumatic brain injury.30 Furthermore, planning and problem solving
was assessed by the total correct score of the Zoo Map Part 1 of the Behavioral
Assessment of the Dysexecutive Syndrome for Children which was administered from
8 years onward. The Zoo Map part 1 has adequate reliability. The validity of this test
seems questionable based on the little data that is presented in the manual.31 Parents
and teachers completed the Behavior Rating Inventory of Executive Function (BRIEF)
which assessed executive functions. Reliability of this questionnaire is adequate and val-
idity acceptable.32 The total scores of Behavioral Regulation and Metacognition were
used for analysis.
Social adjustment
Social adjustment was assessed by the Child Behavior Checklist (CBCL) and the
Teacher Report Form (TRF) 6–18. The CBCL Social Competence score and the CBCL
and TRF Social Problem subscales were used for analysis. Both questionnaires have
adequate reliability and validity. Reliability for the CBCL and TRF Social Problem
subscales is adequate, but low for the CBCL Social Competence scale. The latter is
explained by the fact that this scale is not aimed at measuring one characteristic like the
Social Problem subscales but measures several skills using different question formats
within one domain.33
Intellectual abilities
Intellectual ability was measured by the WISC-III-NL Similarities, Vocabulary (verbal
IQ; VIQ), Block Design and Object Assembly (performance IQ) subtests in children
aged 6 years and over. In 5-year-olds and in two 6-year-old children for whom the
WISC appeared too difficult (both assessed after surgery), equivalent subtests of the
Wechsler Preschool and Primary Scale of Intelligence˗ III-NL were used. Both intelli-
gence tests have adequate reliability and validity and the reliability of the individual
subtests is acceptable.34 In seven patients (five assessed before and two assessed after
surgery) and one control, a proxy of VIQ was used, based on one verbal subtest. Due to
an error in the administration of Object Assembly, only Block Design was included in
the analyses as a measure of visuospatial ability.
Sample characteristics
Parents provided information on their occupation, education, family structure (e.g. liv-
ing with one or two parents, number of siblings, birth order). Furthermore, parents
were asked about the presence of developmental disorders in their child by means of a
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single open-ended question. Based on parental occupation and education, a SES score
was calculated and used for analysis.35 For BT patients, information about diagnosis
and treatment was collected from medical records. Medical information and data on
family structure were used descriptively.
Procedure
Neuropsychological assessments in Dutch BT patients were conducted by TBK and
Flemish patients were assessed by JL. Intelligence tests and questionnaires in Flemish
patients were administered as part of standard hospital protocol by a colleague neuro-
psychologist of JL. Data in Dutch patients was mostly gathered during one session, in
Flemish patients it was gathered over two sessions. In BT patients, the administration of
tests was not conducted in a fixed order because it was often combined with a standard
clinical assessment. In all cases test administration did not exceed 1.5 hours, contained
frequent breaks and was adjusted to the patient in such a way that the child was still
motivated and able to complete as many tests as possible. Parents received the question-
naires immediately after the introduction of the study. However, because of the nature
of the disease and timely surgical intervention, not all parents were able to complete the
questionnaires before the surgery. All parents were specifically instructed to complete
the questionnaires based on their observations of their child prior to brain surgery.
Parents completed the questionnaires before, during or after the assessment (BRIEF:
34.58 ± 72.68; CBCL: 26.57 ± 75.15; range: 1 to 291 days relative to neuropsychological
assessment). Teachers completed questionnaires after consent of parents and/or patient
was given to approach them (BRIEF: 103.44 ± 111.82; TRF: 92.55 ± 121.78; range: 35 to
287 days relative to assessment).
Test administration in healthy controls took approximately 1 (5–7 year olds) to 1.5 hours
( 8 years). Master Psychology students of the University of Groningen and Catholic
University of Leuven were thoroughly trained by TBK or JL and tests were administered
at the child’s primary school or home in one or two sessions in the following order: TMT,
WISC-III-NL Object Assembly, Digit Span Backward or CMS Numbers Backward,
NEPSY-II-NL ToM, NEPSY-II-NL FAR, WISC-III-NL Similarities and Block Design, SST,
Zoo Map part 1 and WISC-III-NL Vocabulary. Parents (BRIEF: 34.58±72.68; CBCL:
12.37±28.33; range: 7 to 164days relative to assessment) and teachers (BRIEF:
23.51±24.86; TRF: 25.74 ±26.66; range: 9 to 90days relative to assessment) of healthy
controls completed the questionnaires around the time of the assessment. Parents of all
included patients and healthy controls received a short written report of the assessment.
Statistical analysis
Missing data analyses were conducted to explore whether the reason of missing data in
patients might induce a selection bias. Missing data were categorized per test as either
due to disease related factors, time constraints or errors in administration.
Demographic and environmental characteristics of healthy controls and BT patients
were compared using a Mann Whitney U-test for the variable age and chi-square tests
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for categorical variables. Categorical variables that did not meet assumptions of a chi-
square test, were described qualitatively only.
To gain insight in performance of BT patients assessed before or after surgery and to
determine if patients assessed before or after surgery could be treated as one group, age
corrected scores were calculated for tests of which published Dutch normative data were
available (i.e. IQ, FAR, basic ToM and WM). The reason for presenting normative scores
instead of means and standard deviations is that the latter would not be very informative
due to age differences between the two BT patients groups. Because of the small sample
sizes of the groups of BT patients assessed before or after surgery, data was only analyzed
qualitatively. Normative scores were allocated to the following categories: above average
(z> 1), average (-1 z  1), below average (-1> z -2) or impaired (z <-2). No Dutch
normative data was available for the TMT and SST. For these tests the raw scores were
inspected qualitatively. Furthermore, because parents and teachers were asked to rate how
the child was functioning prior to surgery on the BRIEF, CBCL and TRF, comparison of
questionnaire data of BT patients who were assessed before or after surgery was not con-
sidered relevant. If large differences between patients who were assessed before or after
surgery were observed for a particular variable, no further analyses were conducted.
Multiple linear regression analyses or derivatives of regression analyses (i.e. ANOVA
or t-test) were performed to test for differences between patients and healthy controls
while controlling for any relevant demographic variables. VIQ, visuospatial ability, social
skills or social adjustment were used as dependent variables. Raw scores were used for
all analyses with the exception of VIQ which is a composite score that automatically
includes a correction for age. Independent variables were group (patients, healthy con-
trols) and either age (months), gender and/or SES (medium, high). Effects of age, gen-
der, SES and relevant interactions were tested separately and were only included in the
final model if they had a significant effect on the dependent variable (i.e. VIQ, visuo-
spatial ability, basic and complex ToM, WM, cognitive flexibility, CBCL Social
Competence). If only categorical predictors were included in the model, an ANOVA or
t-test was performed. Effect sizes (Cohen’s d, adjusted R2, partial g2) and 95% confi-
dence intervals of means and regression coefficients were calculated.36 If assumptions
for the regression analysis were not met, we checked for the presence of outliers and
performed the analyses with and without these outliers. If needed, log transformations
of the dependent variables were conducted. In case of not normally distributed varia-
bles, healthy controls and BT patients were compared with a Mann Whitney U-test (i.e.
Behavioral Regulation and Metacognition parents and teacher, CBCL and TRF Social
Problems). Effect sizes (g2), medians, interquartile ranges and boxplots were given.37
Results
Missing data
On average and across variables, approximately 80% of missing data of BT patients was
missing due to disease related factors; 20% was missing because of errors in administra-
tion and time constraints during testing. For the planning and problem solving
task, more than half of the data were missing because of medical reasons (e.g. fatigue,
diminished attention, blindness) and sample size was very small (n¼ 7). Therefore,
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outcomes were considered unrepresentative for the BT population and these data
were not reported. Regarding questionnaires, the primary reason for missing data
was non-response which was higher in teachers (range¼ 47%–58%) than
parents (range¼ 8%–13%).
Sample characteristics
Age at assessment did not differ significantly between groups and neither did the distri-
bution of gender and of medium and high SES across groups. A minor difference was
observed between patients and healthy controls concerning birth order, but this
difference was not significant. All other variables (i.e. developmental disorders, number
of siblings and family composition) violated the assumptions of a chi-square
test. However, qualitative inspection revealed no apparent differences between groups
(Table 1). Clinical characteristics of BT patients are presented in Table 2.
Qualitative exploration of data of BT patients assessed before or after surgery
While no marked group differences were observed for VIQ, visuospatial ability, basic
ToM, SST and WM, BT patients assessed after surgery seemed to obtain impaired FAR
scores more often than patients assessed before surgery and healthy controls (Table 3).
Table 1. Demographic and environmental characteristics of brain tumor patients (N¼ 30) and
healthy controls (N¼ 95).
Brain tumor patients Healthy controls Statistical comparison
N (%) / M (SD) range N (%) / M (SD) range
Age (y;m) 8;5 (2;7) 5;0–12;11 8;9 (2;3) 5;1–12;11 U¼ 1298.00, z¼0.73, p¼ .46
Gender v2 (1) ¼ .21, p¼ .65
Female 15 (50%) 52 (55%)
Male 15 (50%) 43 (45%)
Socio-economic statusa v2 (1) ¼ .01, p¼ .92d
Low 1 (4%) 1 (1%)
Medium 18 (64%) 59 (65%)
High 9 (32%) 31 (33%)
Developmental disordersb
AD (H)Dc 3 (10%) 2 (2%)
AD (H)Dþ comorbid disorder 1 (3%) 1 (1%)
Dyslexia 1 (3%) 9 (10%)
Dyscalculia 1 (3%) 1 (1%)
Number of siblingsb
None 2 (7%) 5 (6%)
One 10 (33%) 52 (58%)
Two 15 (50%) 26 (29%)
Three 3 (10%) 6 (7%)
Family compositionb
Lives with one parent 1 (3%) 9 (10%)
Lives with two parents 29 (97%) 80 (90%)
Birth orderb v2 (3)¼ 7.36, p¼ .061
Only child 2 (7%) 5 (6%)
Eldest 7 (23%) 38 (42%)
(one of the) Middle 6 (20%) 5 (6%)
Youngest 15 (50%) 41 (46%)
aBrain tumor patients: 2 missing values, healthy controls: 4 missing values.
bHealthy controls: 6 missing values.
cAD (H)D¼Attention Deficit (Hyperactivity) Disorder.
dStatistical comparison of distributions of medium and high SES.
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Also, patients assessed after surgery performed relatively worse for their age on cognitive
flexibility than those assessed prior to surgery and healthy controls. Therefore, no further
statistical analyses were conducted for FAR and cognitive flexibility performance.
Quantitative comparison of BT patients and healthy controls
Performance of patients and healthy controls on measures of IQ, social skills and social
adjustment can be found in Table 4.
Intelligence
A log transformation normalized VIQ data and a two-way ANOVA was performed.
The interaction effect was not significant (F(1,105)¼ 0.01, p¼ .92, partial g2 < .01).
The model with only the main effects showed a significant result for SES
(F(1,106)¼ 6.44, p¼ .01, partial g2 ¼ .06) while group (F(1,106)¼ 1.01, p¼ .32, partial
g2 ¼ .01) did not contribute significantly. Patients and healthy controls did not differ
regarding visuospatial ability (U¼ 701.00, z¼1.30, p¼ .19, g2 ¼ .02, Figure 2A).
Table 2. Clinical characteristics of brain tumor patients (N¼ 30).
N (%) / M (SD) range
Age at diagnosis (y;m) 8;4 (2;7) 4;11–12;11
Time of postsurgical assessment (days after surgery) 49.5 (61.73) 3–219
Epilepsy at assessment 4 (13%)
Presence of hydrocephalus and/or high ICPa at diagnosis
No 7 (23%)
Hydrocephalus 3 (10%)
High ICP 3 (10%)
Hydrocephalusþ high ICP 17 (57%)
ICP treatment
EVDb 4 (13%)
3rd ventriculostomy 4 (13%)
VPDc 1 (3%)
3rd ventriculostomyþ EVD/VPD 2 (7%)
No additional treatment 19 (63%)
Primary tumor localization
Infratentorial 17 (57%)
Suprasellar 5 (17%)
Supratentorial 6 (20%)
Extra axial 2 (7%)
Diagnosis
Glioma
Pilocytic astrocytoma 10 (33%)
Neuronal/glial tumors (ganglioglioma, desmoplastic infantile
ganglioglioma, unspecified neuroglial tumor)
4 (13%)
Oligodendroglioma 1 (3%)
Ependymoma 1 (3%)
Medulloblastoma 8 (27%)
Craniopharyngeoma 3 (10%)
Other (Ewing sarcoma, rhabdomyosarcoma, pituitary adenoma) 3 (10%)
Extent of surgical resection
Gross total resection 13 (43%)
Partial resection 13 (43%)
Biopsy 4 (13%)
Posterior fossa syndrome after surgery 3 out of 17 (18%)
aICP¼ intracranial pressure.
bEVD¼ extra ventricular drain.
cVPD¼ ventriculo peritoneal drain.
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Social-affective and executive functions
Results indicated that age (b¼ .71, p< .001, B¼ 0.11 [0.09;0.13]) predicted 52% of variance
in basic ToM scores (F(3,109)¼ 41.71, p< .001). Group (b¼ .01, p¼ .92, B¼ 0.07
[1.29;1.44]) and gender (b¼.11, p¼ .10, B¼0.87 [1.93;0.18]) did not contribute sig-
nificantly to the model. Complex ToM performance was significantly influenced by age
(b¼ .41, p< .001, B¼ 0.04 [0.02;0.07]) and gender (b¼.27, p¼ .02, B¼.95
[1.73;0.17]) but not by group (b¼ .02, p¼ .84, B¼ 0.11 [0.96;1.19]). The overall model
fit was 18% (F(3,66)¼ 6.18, p¼ .001). Age (b¼ .38, p< .001, B¼ 0.03 [0.01;0.04]) signifi-
cantly explained WM scores, while group (b¼.01, p¼ .94, B¼0.03 [0.72;0.67]) did
not significantly add to the model (adjusted R2¼ 12%, F(2,98)¼ 8.03, p¼ .001). Healthy
controls and patients did not differ significantly on parent and teacher rated Behavioral
Regulation (parent: U¼ 1247.00, z¼ 0.48, p¼ .63, g2< .01; teacher: U¼ 640.00, z¼ 0.08,
p¼ .94, g2< .01) and Metacognition (parent: U¼ 1135.50, z¼0.26, p¼ .80, g2< .01;
teacher: U¼ 643.50, z¼ 0.12, p¼ .91, g2< .01, Figures 2B to E).
Social adjustment
Regarding CBCL Social Competence, age was a significant predictor (b¼ .23, p¼ .03,
B¼ 0.02 [0.01;0.03]) but group was not (b¼.10, p¼ .34, B¼0.42 [1.28;0.45]). The
total model explained 4% of variance (F(2,91)¼ 3.07, p¼ .05). No significant group
Table 3. Age corrected scores based on published Dutch normative data of the brain tumor patients
that were assessed before (N¼ 15) or after surgery (N¼ 14) for tumor removal and healthy con-
trols (N¼ 95).
Presurgery brain tumor patients Postsurgery brain tumor patients Healthy controls
N (%) N (%) N (%)
Verbal intelligence
Above average 2 (17%)a 3 (25%)a 25 (27%)a
2 (29%)b 3 (30%)b 25 (27%)b
Average 10 (83%)a 7 (58%)a 65 (70%)a
5 (71%)b 6 (60%)b 64 (70%)b
Below average 2 (17%)a 3 (3%)a
1 (10%)b 3 (3%)b
Visuospatial ability
Above average 2 (20%) 13 (14%)
Average 8 (100%) 6 (60%) 74 (81%)
Below average 2 (20%) 4 (4%)
Facial affect recognition
Average 6 (67%) 5 (42%) 47 (50%)
Below average 3 (33%) 2 (17%) 23 (25%)
Impaired 5 (42%) 24 (26%)
Basic theory of mind
Above average 1 (11%) 1 (9%) 9 (10%)
Average 8 (89%) 10 (91%) 79 (85%)
Below average 5 (5%)
Working memoryc
Above average 2 (17%) 2 (22%) 14 (19%)
Average 9 (75%) 5 (56%) 49 (66%)
Below average 1 (8%) 2 (22%) 11 (15%)
aVerbal IQ of all patients and healthy controls based on 1 or 2 subtests.
bVerbal IQ of patients and healthy controls for whom the verbal IQ score was based on 2 subtests.
cNormative data of the Dyslexia Screening Test ranged from 6;6 to 16;6 years, scores of children aged between 6;0 and
6;5 years were therefore not included in this table.42
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differences were found for the TRF (U¼ 376.00, z¼ 0.42, p¼ .67, g2< .01) and CBCL
Social Problem scales (U¼ 890.50, z¼ 0.12, p¼ .37, g2< .01, Figures 2F and G).
Discussion
Newly diagnosed BT patients and healthy controls aged 5 to 12 years did not differ
in performance on IQ and measures of social skills and social adjustment. This is in
line with previous pretreatment studies in newly diagnosed BT patients which
reported scores within the normal range for measures of social adjustment or (par-
ent rated) executive functioning.13–15 We extended these findings by showing no
differences between patients and healthy controls on standardized neuropsycho-
logical tests for social˗ affective and executive functioning. However, inspection of
(normative) scores showed that BT patients assessed after surgery seemed to be
(a) (b) (c)
(d) (e) (f)
(g)
Figure 2. Boxplots of performances of brain tumor patients (N¼ 30) and healthy controls (N¼ 95) on
visuospatial ability, executive functions and social adjustment.
Note. BRIEF¼ Behavior Rating Inventory of Executive Function; CBCL¼ Child Behavior Checklist;
TRF¼ Teacher Report Form; A) N¼ 19 brain tumor (BT) patients and N¼ 91 healthy controls B)
N¼ 27 BT patients and N¼ 87 healthy controls; C) N¼ 27 BT patients and N¼ 87 healthy controls;
D) N¼ 16 BT patients and N¼ 79 healthy controls; E) N¼ 16 BT patients and N¼ 79 healthy controls;
F) N¼ 22 BT patients and N¼ 72 healthy controls; G) N¼ 10 BT patients and N¼ 70 healthy controls.
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impaired on FAR performance more often and performed relatively worse for their
age on a cognitive flexibility task than patients assessed before surgery and healthy
controls. We should be careful in attributing these differences to negative effects of
surgery because 25% of the healthy controls also showed impaired FAR performance
and no normative data was available for the cognitive flexibility task. Additionally,
more severely ill patients were more likely to be assessed after surgery, effects of
surgery are not always negative (e.g. relieve of intracranial pressure) and secondary
(temporary) effects of illness and treatment like tiredness, pain or effects of general
anesthetics might also have played a role.
It is encouraging that there were no significant differences between patients and
healthy controls on measures of social skills and adjustment shortly after diagnosis
and that only relatively few patients showed clinically impaired social skill perform-
ance. However, we cannot simply assume that the development of social competence
in patients will follow a normal trajectory. Besides adverse effects of the tumor and/
or surgery, late effects of CRT have also been suggested as a possible risk factor for
diminished social skills and adjustment.7,9,20 Second, also patients who have not
received CRT may later develop (more) problems that were not present around
the time of diagnosis.2 This phenomenon is known as growing into deficit and may
pose a risk to the development of social competence in BT survivors.38 The age
effects that were found in the current sample confirm the ongoing development of
social-affective and executive functions in middle childhood.16–18 Because of this
continued development, the full impact of brain damage on social competence in
BT survivors will not be clear until development is completed. These concerns are
supported by retrospective studies in BT survivors that indicated significant deficits
in social˗ affective and executive functioning and social adjustment several years
after treatment.4,7–10
Study limitations and implications
Our study comes with certain limitations (i.e. relatively small sample size, heterogeneity
of the sample regarding age, diagnosis and presentation of the disease as well as differ-
ences in timing of assessment) which are part of performing a prospective study in
severely ill children. Because of their illness, there were more missing data for BT
patients than for healthy controls. This might have resulted in an overrepresentation of
scores of patients that were least affected by disease or surgery, with possibly less
affected cognitive and behavioral functioning, because they were most likely to complete
the entire assessment. Furthermore, assessments in BT patients were not as standardized
as in healthy controls, since they had to be adjusted to the individual needs and disabil-
ities of patients. Although not all tests show adequate reliability and validity and adjust-
ments to standard assessment were made, we are confident that we have selected the
best test battery possible from the tests that were available at the start of this study.
Furthermore, we have no reason to believe that the selected tests and questionnaires
were inadequate in addressing social competence problems experienced by pediatric BT
patients. The complexities of daily (social) life are obviously not fully captured by
administering neuropsychological tests in a standardized setting. Most tests of social-
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affective functioning are rather structured and mostly involve children’s responses on
hypothetical social situations.39 Nevertheless, neuropsychological studies are relevant for
understanding and treating social competence problems in BT patients.40 Future studies
could, however, further focus on the development of more ecologically valid measures
of social-affective functioning in children. In addition, they could also include standar-
dized observation during assessment to study social interaction and include patient
reports or peer ratings to assess social adjustment in more detail.41 Within the present
study, several environmental factors were assessed that could be of influence on social
competence. These factors focused on the family context (e.g. SES, family structure). It
would be interesting to also address the social context (e.g. social support, peer accept-
ance) and more psychological family factors (e.g. family functioning, parental coping) in
future research.5,39
Conclusion
The results of the current study are an important starting point in studying social com-
petence after treatment of a BT in childhood because this is the first study that looks
into multiple levels of social competence in newly diagnosed BT patients. The results
show that, on average, performance of patients did not differ from healthy controls on
measures of IQ, social skills and social adjustment. It is comforting and of clinical and
scientific relevance for patients, their families and clinicians to know that social compe-
tence, despite its complexity, appears not to be significantly affected in the early stage of
the disease. However, only the combination of the current findings with the follow-up
of this sample will enable us to make more specific recommendations regarding clinical
management of these problems. Adjuvant treatment, particularly CRT, may contribute
to later poor social skills and adjustment. Furthermore, brain damage related to the
tumor and/or surgery may only result in obvious deficits many years later. Therefore,
more prospective longitudinal studies with larger samples of patients would contribute
to the understanding of long-term development of social competence in pediatric
BT survivors.
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